Navigation Links
Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets
Date:10/7/2010

rug applications or supplemental drug applications that have been or may be filed for any such oncology product candidates or any such additional indications for in-line oncology products as well as their decisions regarding labeling and other matters that could affect their availability or commercial potential; and competitive developments.

A further description of risks and uncertainties can be found in Pfizer's Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.

(1)  ESMO Accepted Abstract #365PD. Randomized phase 2 study of PF299804, an irreversible human epidermal growth factor receptor (EGFR) inhibitor, versus (v) erlotinib (E) in patients (pts) with advanced non-small cell lung cancer (NSCLC) after chemotherapy (CT) failure: quantitative and qualitative benefits. Poster Discussion. Sunday, October 10: 12:30 pm. Suresh Ramalingam – Presenter. 35th Congress of the European Society for Medical Oncology. Milan, Italy. October 8 - 12, 2010.  

(2)  ESMO Accepted Abstract # LBA18. Efficacy and safety of PF299804 as first-line treatment (tx) of patients (pts) with advanced non-small cell lung cancer (NSCLC) selected for activating mutation (mu) of epidermal growth factor receptor (EGFR). Proffered Paper (Oral Presentation). Monday, October 11: 14:00. Tony Mok - Presenter. 35th Congress of the European Society for Medical Oncology. Milan, Italy. October 8 - 12, 2010.  

(3)  ClinicalTrials.gov. PF-00299804 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Standard Therapy for Advanced or Metastatic Cancer. Available at: http://clinicaltrials.gov/ct2/show/NCT01000025.  Accessed April 29, 2010.

(4)  ESMO Accepted Abstract # 366PD. Clinical Activity of Crizotinib (PF-02341066), in ALK-Positive Patients with
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... MENLO PARK, Calif. , July 6, 2015 /PRNewswire/ ... of its 2015 Internal Auditing around the World ... decade, Protiviti has analyzed and reported on the evolution ... select companies from around the globe as a means ... a deeper understanding of this strategic business function. ...
(Date:7/6/2015)... 6, 2015 Hologic, Inc. (NASDAQ: HOLX ... its financial results for the third quarter of fiscal ... closes.  In conjunction with the release, management will host ... Time. Interested participants may listen to the ... States ) or 719-325-4804 (for international callers) and ...
(Date:7/6/2015)... 6, 2015 E-QURE Corp (OTCQB: EQUR), today ... at VirtualInvestorConferences.com on July 9, 2015. DATE: Thursday, ... This will be a live, ... the company questions in real-time - both in the ... booth." If attendees are not able to join the ...
Breaking Medicine Technology:New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2
... PharmacoFore, Inc., a privately held biopharmaceutical company ... results from a Phase I human proof-of-concept (hPOC) ... (Bio-MD™) product candidate, PF329.  Greg Sturmer, VP, Finance ... Business Forum during the annual BIO International Convention ...
... AUSTIN, Texas, June 23, 2011 Luminex Corporation (NASDAQ: ... Awards - Stevie Awards - Most Innovative Company of ... and Business Innovation of the Year for the MAGPIX ... year with more than 2,800 organizations from virtually all ...
Cached Medicine Technology:PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 2PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 3PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 4Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System 2Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System 3
(Date:7/6/2015)... ... July 06, 2015 , ... In order to recognize ... Orthopaedic Society for Sports Medicine ( AOSSM ) will present ten research awards ... As a leader in orthopaedic sports medicine, AOSSM annually provides more than $350,000 ...
(Date:7/6/2015)... ... July 06, 2015 , ... Hundreds of thousands of ... which is why liposuction regularly ranks among the top five most popular cosmetic ... become more than a way to slim down a silhouette for swimsuit season. ...
(Date:7/6/2015)... ... July 06, 2015 , ... Longevity, ... has partnered with Woodbridge Walk-In Urgent Care to offer on-site health screenings. These ... medical conditions. Screenings are affordable and accurate and run about an hour long ...
(Date:7/6/2015)... ... July 06, 2015 , ... MD Now, the leading and fastest-growing urgent ... constructed urgent care center will serve residents and visitors in the Cutler Bay area, ... Now’s 22nd South Florida location, the new facility will be the fourth to serve ...
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now offering the ... Kybella is a non-surgical method to dissolve fat cells and is the first ... fat deposits under the chin, commonly known as a double chin. Dr. Green participated ...
Breaking Medicine News(10 mins):Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 3Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 5Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 6Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2
... how they help arteries stay clear and healthy , TUESDAY, ... researchers have begun to discover the exact molecular reasons why ... and ordinary orange juice are good for the health of ... studies describing the range of genes that are affected by ...
... , , OWINGS MILLS, Md., ... leading portion-controlled weight-loss program, today announced the launch of Honey Mustard ... and Parmesan Cheese Puffs. The new pretzel sticks and cheese puffs ... & 1 Plan, while also maintaining the nutritional value of Medifast ...
... to Treat Diseases (HTDS.PK) www.htdsmedical.com announced today ... the country of Thailand. The registration is expected to ... This registration is required to accommodate a customer from ... products such as MEVAC-A, MEVAC-DTaP, and MEVAC-ACYW. , Mellow ...
... N.H., July 21 Emerson Ecologics, LLC today announced that ... Michelle will develop and implement new business opportunities while maintaining ... , , "Michelle brings a ... this important new position," said Fran Towey, CEO of Emerson ...
... (July 21, 2009) Columbia University Medical Center,s Jeffrey ... of schizophrenia, has been selected by the National Institute ... Health as principal investigator of a nationwide effort to ... experiencing a first episode of the psychotic symptoms of ...
... Chinese patients will soon have the opportunity to take ... at reversing the autoimmune disease, ankylosing spondylitis. Approximately 200 ... trial that aims to merge the latest molecular discoveries ... with the medical expertise of physicians and researchers at ...
Cached Medicine News:Health News:Studies Show Genetic Activity of Antioxidants 2Health News:Studies Show Genetic Activity of Antioxidants 3Health News:Medifast Adds Pretzel and Puffs to Meal Replacement Line 2Health News:Medifast Adds Pretzel and Puffs to Meal Replacement Line 3Health News:Hard To Treat Diseases (HTDS.PK) Thailand Registration 2Health News:Emerson Ecologics Names Michelle Hebert New England Regional Sales Representative 2Health News:Columbia leads national effort to develop early intervention for schizophrenia 2Health News:Columbia leads national effort to develop early intervention for schizophrenia 3Health News:Study aims to induce recovery from ankylosing spondylitis 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: